Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
₹72 Cr
P/E Ratio
62.81
P/B Ratio
1.38
Industry P/E
40.04
Debt to Equity
0
ROE
1.88 %
ROCE
2.82 %
Div. Yield
0 %
Book Value
37.88
EPS
0.83
CFO
₹-11.00 Cr
EBITDA
₹-0.11 Cr
Net Profit
₹-1.10 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Eiko Lifesciences
| -15.52 | -9.40 | -5.81 | -7.36 | 8.15 | 50.05 | -- |
|
BSE Commodities
| 3.75 | 2.16 | 5.71 | 7.40 | 7.39 | 29.67 | -- |
|
BSE Small Cap
| -10.10 | 4.14 | -4.75 | 8.42 | 18.83 | 36.06 | 15.83 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
|
|---|---|---|---|---|---|
|
Eiko Lifesciences
| 0.84 | 51.47 | -33.06 | 111.89 | 124.42 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 |
|
BSE Commodities
| 8.14 | 17.51 | 1.22 | 61.53 | 26.07 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 826.45 | 10,812.73 | 101.34 | -- | |
| 810.05 | 8,806.05 | 110.51 | 2.87 | |
| 10,059.95 | 8,002.88 | 57.34 | 17.46 | |
| 686.75 | 10,737.94 | 52.03 | 7.43 |
No Review & Analysis are available.
Trusts, funds and other financial vehicles
Incorporated
1977
Chairman
Laxmikant Ramprasad Kabra
Managing Director
--
Headquarters
Thane, Maharashtra
Website
Looking for more details about Eiko Lifesciences Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Eiko Lifesciences Ltd stood at ₹ 55 Cr as on 31-Dec-24
The share price of Eiko Lifesciences Ltd is ₹53.00 (BSE) as of 22-Apr-2025 10:48 IST. Eiko Lifesciences Ltd has given a return of 8.15% in the last 3 years.
Eiko Lifesciences Ltd has a market capitalisation of ₹ 72 Cr as on 21-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Eiko Lifesciences Ltd is 1.38 times as on 21-Apr-2025, a 56% discount to its peers’ median range of 3.14 times.
The P/E ratio of Eiko Lifesciences Ltd is 62.81 times as on 21-Apr-2025, a 57% premium to its peers’ median range of 40.04 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Eiko Lifesciences Ltd and enter the required number of quantities and click on buy to purchase the shares of Eiko Lifesciences Ltd.
Trusts, funds and other financial vehicles
The prominent promoters of Eiko Lifesciences Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
LENUS FINVEST PRIVATE LIMITED |
17.01%
|
|
LAXMIKANT KABRA (HUF) |
10.24%
|
|
SIDDHANT LAXMIKANT KABRA |
5.31%
|
The chairman of the company is Laxmikant Ramprasad Kabra, and the managing director is .
There is no promoter pledging in Eiko Lifesciences Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
10,988
|
|
|
10,551
|
|
|
8,904
|
|
|
8,042
|
| Eiko Lifesciences Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
2.26
|
|
Operating margin(%)
|
3.11
|
|
Net Margin(%)
|
3.35
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Eiko Lifesciences Ltd was ₹1 Cr.
₹0.80
(
